In March, we anticipated sunshine and warmer days while keeping up with the latest health policy research. We read about marketplace plan deductibles, physician turnover in private-equity acquired practices, and estimated savings from prescription drug rebates.
In recently proposed regulatory changes to marketplace coverage, the Trump Administration intends to strip Deferred Action for Childhood Arrivals (DACA) recipients of eligibility for marketplace coverage. This proposal represents the latest twist in the roller coaster of policy changes and litigation DACA recipients have endured.
CMS recently finalized a change in the 2025 Notice of Benefit and Payment Parameters, granting states the flexibility to update essential health benefit (EHB) benchmark plans. In this post, CHIR experts reflect on recent state updates to EHB and adult dental coverage.
Last fall, the Biden Administration finalized a rule updating standards for the Mental Health Parity and Addiction Equity Act (MHPAEA). In their latest piece for the Commonwealth Fund, CHIR’s JoAnn Volk and Billy Dering discuss the new requirements for use of “non-quantitative treatment limits” that impose significant barriers to behavioral health treatment.
Peter Nelson, the new director of the Center for Consumer Information and Insurance Oversight (CCIIO) has brought a long forgotten ACA provision back into the spotlight. CHIR’s Stacey Pogue breaks down Section 1333 compacts, what it would mean for consumers, and concerns for implementation.
On March 23, 2025, we celebrated the 15th anniversary of the Affordable Care Act (ACA). In this post, CHIR experts reflect on how the law’s reforms affected people’s access to affordable, high quality health insurance, and what the next 15 years might bring.
Over the last two months, CHIR hosted a three-part webinar series about the corporate transformation of health care. Kennah Watts discusses some unanswered questions from the series relating to price caps, transparency, and rural hospitals, and highlights further CHIR resources on the subject.
In February we stayed out of the cold and bundled up with the latest in health policy research. We read about salary and utilization changes in hospitals acquired by private equity, challenges with price transparency requirements, and changes to hospital community benefit rules in Oregon.
High and rising healthcare costs in the U.S. are driven largely by escalating hospital prices, fueled by increasing consolidation among health systems. In a recent Issue Brief for the Milbank Memorial Fund, Sabrina Corlette and Karen Davenport discuss what states can do to enhance premium rate review programs, to ultimately curb provider price increases.
Private equity is not new to the health care sector, but recent growth in private equity investment has sparked a plethora of research studies, media attention, and political attention. A recent Congressional investigation and agency report, on top of continuing research indicate the time for policymakers to take action against private equity in health care is now.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
